Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven C H Kao

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Psycho-Oncology|September 30, 2010
Patient and oncologist estimates of survival in advanced cancer patientsSteven C H Kao, Phyllis Butow, Victoria Bray, et al.
Frontiers in Genetics|June 8, 2013
The Impact of Hemolysis on Cell-Free microRNA BiomarkersMichaela B Kirschner, J James B Edelman, Steven C-H Kao, et al.
Clinical Lung Cancer|October 23, 2012
Excision repair cross complementation group 1 and thymidylate synthase expression in patients with mesotheliomaSteven C H Kao, Kenneth Lee, Sonja Klebe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2010
High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapySteven C H Kao, Nick Pavlakis, Rozelle Harvie, et al.
Pathology|January 15, 2011
Validation of tissue microarray technology in malignant pleural mesotheliomaSteven C H Kao, Kenneth Lee, Nicola J Armstrong, et al.
The Lancet. Oncology|September 5, 2020
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-inAnna K Nowak, W Joost Lesterhuis, Peey-Sei Kok, et al.
Cell Reports. Medicine|December 28, 2024
Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapyWee Loong Chin, Alistair M Cook, Jonathan Chee, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Psycho-Oncology|September 30, 2010
Patient and oncologist estimates of survival in advanced cancer patientsSteven C H Kao, Phyllis Butow, Victoria Bray, et al.
Frontiers in Genetics|June 8, 2013
The Impact of Hemolysis on Cell-Free microRNA BiomarkersMichaela B Kirschner, J James B Edelman, Steven C-H Kao, et al.
Clinical Lung Cancer|October 23, 2012
Excision repair cross complementation group 1 and thymidylate synthase expression in patients with mesotheliomaSteven C H Kao, Kenneth Lee, Sonja Klebe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2010
High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapySteven C H Kao, Nick Pavlakis, Rozelle Harvie, et al.
Pathology|January 15, 2011
Validation of tissue microarray technology in malignant pleural mesotheliomaSteven C H Kao, Kenneth Lee, Nicola J Armstrong, et al.
The Lancet. Oncology|September 5, 2020
Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-inAnna K Nowak, W Joost Lesterhuis, Peey-Sei Kok, et al.
Cell Reports. Medicine|December 28, 2024
Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapyWee Loong Chin, Alistair M Cook, Jonathan Chee, et al.
Pageof 1